欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/7095/001
药品名称Fingolimod beta 0,5 mg Hartkapseln
活性成分
    • fingolimod hydrochloride 0.5 mg
剂型Capsule, hard
上市许可持有人Betapharm Arzneimittel GmbH Kobelweg 95 86156 Augsburg Germany
参考成员国 - 产品名称Germany (DE)
Fingolimod beta 0,5 mg Hartkapseln
互认成员国 - 产品名称
    • Sweden (SE)
    • Romania (RO)
      Fingolimod Dr. Reddy’s 0,5 mg capsule
    • Norway (NO)
    • Slovakia (SK)
    • Finland (FI)
    • Poland (PL)
      Fingolimod Reddy
    • Czechia (CZ)
      Fingolimod Reddy
    • Denmark (DK)
    • Belgium (BE)
      Fingolimod Reddy 0,5 mg harde capsules
    • Netherlands (NL)
    • Portugal (PT)
许可日期2022/02/18
最近更新日期2024/04/22
药物ATC编码
    • L04AA27 fingolimod
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase